From: The 2024 Saudi Pharmacotherapy Didactic Curriculum Toolkit: A Modified Delphi Study
Panel members | N = 56 |
---|---|
Sex | |
Female | 30 (53.5) |
Male | 26 (46.43) |
Geographical Location | |
Central | 32 (57.14) |
Western | 14 (25) |
Eastern | 9 (16.07) |
Southern | 1 (1.79) |
Northern | 0 (0) |
Additional Degree(s)/ Training (Post-Bachelor) | |
Post Bachelor Pharm.D. | 16 (30.19) |
PGY1 | 34 (64.15) |
Master’s degree | 11 (20.75) |
PGY2 | 41 (77.36) |
Fellowship | 9 (16.98) |
Others | 5 (9.43) |
Earned Board Certification | |
Pharmacotherapy | 27 (48.2) |
Ambulatory Care Pharmacy | 7 (12.50) |
Critical Care Pharmacy | 7 (12.50) |
Cardiology Pharmacy | 6 (10.71) |
Infectious Diseases Pharmacy | 4 (7.14) |
Oncology Pharmacy | 4 (7.14) |
Medication Therapy Management | 4 (7.14) |
Pediatric Pharmacy | 3 (5.36) |
Solid Organ Transplantation Pharmacy | 2 (3.57) |
Nutrition Support Pharmacy | 1 (1.79) |
Others | 6 (10.71) |
Years of Experience | |
1–5 years | 12 (21.43) |
6–10 years | 25 (44.64) |
11–15 years | 12 (21.43) |
16–20 years | 6 (10.71) |
21 years or more | 1 (1.79) |
Affiliated Institution | |
Governmental | 39 (69.64) |
Military | 11 (19.64) |
Private | 4 (7.14) |
Governmental and Private | 2 (3.57) |